key: cord-1017484-0be321n4
authors: Mittal, Anugya; Elias, Marcus L.; Schwartz, Robert A.; Kapila, Rajendra
title: Recognition and treatment of devastating vasculopathic systemic disorders: Coronavirus disease 2019 and rickettsioses
date: 2021-05-29
journal: Dermatol Ther
DOI: 10.1111/dth.14984
sha: 8f99ad55df4cb5398cb84c519ba5c199d96894a7
doc_id: 1017484
cord_uid: 0be321n4

Cutaneous involvement can be an important sign of both COVID‐19 and rickettsioses. Rickettsial infections may be first evident as an exanthem with eschars as a key finding. In contrast, eschars and necrotic lesions can be seen in critically ill COVID‐19 patients. Both illnesses share a similar mechanism of infecting endothelial cells resulting in vasculopathy. Rickettsia parkeri and Rickettsia 364D are both characterized by eschars unlike Rickettsia rickettsii. Other eschar causing rickettsioses such as Rickettsia conorii, Rickettsia africae, and Orientia tsutsugamushi are commonly diagnosed in people from or having traveled through endemic areas. While there is no consensus on treatment for COVID‐19, rickettsioses are treatable. Due to possibly serious consequences of delayed treatment, doxycycline should be administered given an eschar‐presenting patient's travel history and sufficient suspicion of vector exposure. The proliferation of COVID‐19 cases has rendered it critical to differentiate between the two, both of which may have overlapping vasculopathic cutaneous findings. We review these diseases, emphasizing the importance of cutaneous involvement, while also discussing possible therapeutic interventions.

typically appear as erythematous macules that can develop into petechiae or vesicles. Eschars represent cutaneous necrosis and a pivotal diagnostic clue in most rickettsioses, except for Rocky Mountain spotted fever (RMSF). These lesions can be mistaken for Staphylococcus aureus abscesses and other pyogenic infections. 10 Travelers with suspected skin infections and eschars are commonly infected with Rickettsia, S. aureus, or S. pyogenes. 11 When mistaken for another etiology, patients are often treated with beta-lactam antibiotics, which have no efficacy on the gram-negative Rickettsia. When not considereing these clinical diagnoses, rickettsial diseases can be missed, leading to severe consequences. There are three main rickettsioses associated with eschars in the United States: Rickettsia parkeri, Rickettsia akari, and Rickettsia 364D. Across the world, Rickettsia conorii, Rickettsia africae, and Orientia tsutsugamushi are common causes of febrile illnesses associated with eschars. 12 Other eschar causing rickettsioses from around the world such as Rickettsia slovaca, Rickettsia sibirica, Rickettsia japonica, Rickettsia australis, and Rickettsia heilongjiangensis are not included as they are less likely to be encountered in practice. 5, 13 Although Rickettsia rickettsii does not typically cause an eschar, it has been included in this review. 14 

This review includes articles from searching the databases "PubMed"

and "Google Scholar" using the keywords "COVID-19", "SARS-CoV-2", "vasculopathic", "endotheliitis", "Rickettsioses", and "eschar".

Other keyword terms searched were related to the specific Rickettsia discussed in this review. Articles that were released on or prior March 8, 2021 were included.

Rickettsial species have a unique natural disease course for bacteria.

The genus has a high affinity for the endothelium lining of blood vessels, resulting in vascular inflammation and permeability. 7 Bacterium from the SFG escape from the cell and damage the endothelial cell's semi-permeable membrane. The pathogenesis of the cutaneous eschars arises from focal areas of endothelial proliferation and perivascular mononuclear cell infiltration, causing third-spacing. These vascular lesions, along with thrombosis and necrosis of capillaries, form eschars. 13 The human immune response in clearing the infection is largely T-cell mediated. Cell-mediated release of interferon-gamma activates the infected endothelial cells to present intracellular rickettsial antigens to CD8+ T-cells killing the infected cells. 13 While the pathophysiology of COVID-19 is still being delineated, in vitro studies of blood vessel organoids indicate that SARS-CoV-2 can directly infect endothelial cells. 15 Angiotensin-converting enzyme 2, a receptor expressed in endothelial cells and the epithelial lining in the lungs, small intestine, and heart, acts as the entry point for SARS-CoV-2. 16 Histological analyses from COVID-19 patients show viral inclusion bodies and inflammatory cells within endothelial cells, leading to endotheliitis. 6 This finding indicates that the inflammation is a direct response to the virus infecting the cell and not a secondary response. More specifically, critically ill patients who developed thrombotic retiform purpura had higher SARS-CoV-2 proteins in the endothelium in contrast to those with milder presenting disease that developed chilblains like lesions. 17 This cutaneous manifestation in critically ill patients may be the result of complement activation by the spike proteins of SARS-CoV-2.

As both rickettsial infections and COVID-19 can lead to multiple organ dysfunction, it is critical to examine the role that cytokines play.

A lack of anti-inflammatory regulatory cytokines, such as IL-10 in scrub typhus, may contribute to a cytokine storm and the development of acute respiratory distress syndrome (ARDS). 18 Other proinflammatory cytokines, such as IL-6, are also produced in patients with rickettsia-infected endothelial cells due to the activation of nuclear factor κB. 13 The role of cytokines has been investigated more in relation to COVID-19 due to the devastating sequelae of these cytokine storms. High levels of IL-6 are affiliated with the secretion of vascular endothelial growth factor and reduced expression of E-cadherin on endothelial cells, resulting in increased vascular permeability. Elevated levels of other chemokines, including but not limited to IL-10, are associated with increased severity of illness and outcomes such as ARDS, sepsis, and multiple organ failure. 16 

While common clinical symptoms of COVID-19 include fever, cough, diarrhea, fatigue, and hyposmia, a variety of cutaneous presentations may be evident. In general, dermatologic findings in patients can be categorized as maculopapular, vesicular, chilblain-like, urticaria, and vascular. 3 Maculopapular exanthems typically arise on the trunk and can spread diffusely while sparing the palms, feet, and face. On histology, lesions have a perivascular lymphocytic infiltrate with variable presentation of eosinophils and histiocytes depending on the time of onset. [19] [20] [21] [22] Urticarial lesions, a common skin manifestation of COVID-19, tend to be generalized and present either prior to or simultaneously with other clinical symptoms. 19, 20, 23 Both urticarial and maculopapular lesions may also be a consequence of adverse drug reactions in patients treated with combination pharmacological therapies consisting of antivirals and antimalarials, with generalized pustular figurate erythema linked specifically with hydroxych loroquine. 3, 21, 22, 24 Therefore, caution should be exercised when diagnosing patients with these mucocutaneous reactions.

There are two presentations of vesicular exanthems: localized and diffuse. 3 Diffuse vesicular rashes are polymorphic while localized vesicular rashes are monomorphic and involve the trunk.

These exanthems can be confused with chickenpox or other viral infections. [19] [20] [21] 25 Chilblain-like eruptions are more commonly found in younger patients and appear erythematous and edematous. They seem to preferentially affect the toes and fingers asymmetrically and indicate a better prognosis. 3, 19, 21, 22 Cases of chilblain-like lesions persisting in patients for over 60 days after initial onset have also been reported. Despite patients with these lesions having milder infections, their persistence indicates continued inflammation. 26 Vascular manifestations such as livedoid eruptions, necrosis, and dry gangrene are more likely to present in severely ill patients. These lesions can be found in the sacrum region as well as the extremities causing acro-ischemia. 3, 19, 21, 27 

Within the SFG, RMSF has the highest mortality rate of up to 40%-50% with delayed initiation of treatment, and has been increasing in incidence within the United States. 14 R. rickettsii, the pathogen responsible for RMSF, is most commonly transmitted by Dermacentor variabilis east of the Great Plains and Dermacentor andersoni in the Rocky Mountains and western states of the United States. 28 RMSF does not typically present with an eschar. Although high fever is the most common symptom, patients also have rash, headaches, nausea, and diarrhea. The rash typically begins as blanching pink macules that often progress to either maculopapular or petechial morphologies due to the leakage of fluid from vasodilated vessels and hemorrhage, respectively. The erythematous macules usually first appear on the wrist and ankles and then progress towards the trunk. Due to nonspecific abdominal symptoms, RMSF is often confused with gastroenteritis. 28 Without intervention, RMSF can cause several systemic complications such as septicemia, gangrene, hepatosplenomegaly, and central nervous system abnormalities. 29 Rickettsialpox is caused by Rickettsia akari. Unlike other rickettsioses, it is not transmitted by ticks, but instead by the mouse mite Liponyssoides sanguineus, which infests the common house mouse Mus musculus. Rickettsialpox was first described in New York City and has since been identified across urban centers in Europe, North America, Asia, and South Africa. 5 Once bitten by the mouse mite, patients develop a high fever, papulovesicular rash, and painless eschar ( Figure 1 ). The rash is relatively sparse, non-pruritic, and monomorphic. Other symptoms such as myalgias, lymphadenopathy, and headaches have also been reported. 30 Rickettsialpox can be misdiagnosed as hand-foot-mouth disease, herpes, and most commonly, chickenpox due to the appearance of vesicules. 31 Rickettsial parkeri rickettsiosis is mainly transmitted by Ambylomma maculatam along the southeastern coastal area of the United States and some inland states. 14, 32 Although it has a milder clinical presentation than RMSF, its prevalence may be higher than previously thought due to non-selective assays which cannot sufficiently distinguish between the antigens associated with R. rickettsii and R. parkeri. 32 Common symptoms include mild fever, exanthemas, and eschars which appear 6 to 10 days after being bitten by an infected tick. Patients can have multiple eschars that are typically crusted, nonpruritic, and surrounded by an indurated, erythematous halo. In addition, some may develop a maculopapular or vesiculopapular eruption. 33 Pacific Coast tick fever (PCTF) is also endemic to the United States and is caused by Rickettsia 364D transmitted by Dermacentor occidentlis. Patients with PCTF typically have an eschar, multiple in some cases. Other common symptoms include fever, general malaise, myalgias, headache, and lymphadenopathy. In contrast to RMSF, patients with PCTF often have a milder presentation without a rash.

However, some patients may still require hospitalization. 34 Rickettsia conorii causes Mediterranean Spotted Fever and has several different strains with varying case-fatality rates. Transmitted by the Rhipicephalus sanguineas, this pathogen is found throughout Europe, the Indian subcontinent, and Africa. It is typically associated with an eschar as a result of an indurated papule with central necrosis at the inoculation site along with a widespread maculopapular rash.

Fever, headaches, and myalgias are other non-specific symptoms. 35 F I G U R E 1 Rickettsialpox. Originally misdiagnosed as chickenpox until the discovery of an eschar, Rickettsialpox produces vesicles and is an urban disease F I G U R E 2 African tick bite fever. Rickettsia africae infection, mistaken for a common pyogenic abscess, in a person returning from a safari in the Republic of South Africa An unusual manifestation of this disease is the development of a fernleaf shaped necrotic skin rash and purpura fulminans, which can progress to necrosis. Some of the most common infectious agents that can also cause purpura fulminans include Neisseria meningitidis, Pseudomonas aeruginosa, Haemophilus influenzae, and methicillin-resistant S. aureus. 36 Rickettsia africae causes ATBF (Figure 2) . Transmitted by the Amblyomma herabeum, R. africae resides mainly in sub-Saharan Africa.

Despite its name, ATBF is also endemic in the Caribbean, and consideration should extend to those travelers. 5 ATBF is the most common rickettsioses among tourists who have traveled to endemic regions in sub-Saharan Africa on safaris. 37 It commonly presents with multiple eschars, a generalized cutaneous exanthem, fever, myalgias, and headaches. An erythematous halo and maculopapular rash may surround the black crusted inoculation eschar. 38 While this disease typically has a benign course, patients can also develop acute myocarditis or cranial subacute neuropathy. 37 Scrub typhus, an infection caused by Orientia tsutsugamushi, is widespread throughout much of Southeast Asia and can have high mortality rates between 30-70% if left untreated. This organism is transmitted via Leptotrombidium mites in more rural areas. 9 While non-specific symptoms include fevers, headaches, myalgias, conjunctivitis, lymphadenopathy, and nausea, many patients also exhibit eschars. 9 The differences in eschar presentation between Asian the need for amputations due to irreversible injury has been documented in patients with both COVID-19 or rickettsioses. 14, 43 Although disseminated intravascular coagulation (DIC) has been strongly associated with severely ill COVID-19 patients, DIC is rarer in patients with rickettsioses. 3, 13 The cutaneous manifestations of DIC in patients with COVID-19 have varied from acro-ischemia to petechial patterns. 44 The multi-organ involvement in RMSF, Mediterranean spotted fever, and scrub typhus may have a similar presentation as in COVID-19, and therefore should be considered when examining patients with fever, rash, and a history of possible exposure to ticks, usually between the months of April to September. [2] [3] [4] 9, 25 While the clinical presentation of rickettsioses differs based on the organism responsible, there are many similarities. In general, patients are first seen with a high fever and an exanthem. Other symptoms include lymphadenopathy, eschars, hepatosplenomegaly, headaches, nausea, and diarrhea. A full patient history may reveal potential exposure to arthropods such as ticks or mites as well as

travel. Co-infections should be carefully considered as they may account for some of the symptoms. 10 Furthermore, due to the nonpruritic nature of eschars, patients may not even notice them and, therefore, a thorough examination of the patients should be conducted in cases of an unspecified febrile illness. Other differential diagnoses for a patient with a fever and eschar include mucormycosis, anthrax, necrotizing fasciitis, and bacterial or fungal sepsis ( Figure 3 ). 45 

The authors have no conflict of interest to declare.

All four authors made substantial contributions to the conception, design and/or acquisition of the data in this work and approved the final submission.

Data availability statement: Data that supports the following information are available from the first author upon reasonable request.

Robert A. Schwartz https://orcid.org/0000-0003-3036-3825

COVID-19 Dashboard. Johns Hopkins Coronavirus Resource Center

Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei Province

Coronavirus Disease-2019 with dermatologic manifestations and implications: an unfolding conundrum

Cutaneous manifestations of COVID-19: an evidence-based review

Rickettsial diseases (including spotted fever & typhus fever rickettsioses, scrub typhus, anaplasmosis, and ehrlichioses)

Endothelial cell infection and endotheliitis in COVID-19

Infection of the endothelium by members of the order rickettsiales

Plasmids and rickettsial evolution: insight from rickettsia felis

A review of the global epidemiology of scrub typhus

Cutaneous leishmaniasis and rickettsial African tick-bite fever: a combination of exotic traveler's diseases in the same patient

Seek and find! PCR analyses of skin infections in west-European travelers returning from abroad with an eschar

Description of eschar-associated rickettsial diseases using passive surveillance data -United States

Rickettsiae and rickettsial infections: the current state of knowledge

Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis-United States

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2

Molecular pathogenesis, immunopathogenesis and novel therapeutic strategy against COVID-19

The differing pathophysiologies that underlie COVID-19 associated perniosis and thrombotic retiform purpura: a case series

Cross-regulation of Proinflammatory cytokines by Interleukin-10 and miR-155 in Orientia tsutsugamushiinfected human macrophages prevents cytokine storm

Cutaneous signs in COVID-19 patients: a review

Cutaneous manifestations in hospitalized patients diagnosed as COVID -19

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Cutaneous manifestations of COVID-19: a systematic review

Urticaria and COVID-19: a review

Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine

Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

Large sacral/buttocks ulcerations in the setting of coagulopathy: a case series establishing the skin as a target organ of significant damage and potential morbidity in patients with severe COVID -19

Tick-transmitted infectious diseases in the United States

Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases

Rickettsialpox in new York City: a persistent urban zoonosis

Rickettsialpox: case report and epidemiologic review

Novel PCR exclusion assay to detect spotted fever group rickettsiae in the lone star tick (Amblyomma americanum)

Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever

The eco-epidemiology of Pacific coast tick fever in California

Mediterranean spotted fever in Lombardy: an epidemiological, clinical and laboratory study of 76 cases in the years 1977-1986

Rare presentation of rickettsial infection as purpura fulminans: a case report

Multicenter Geo-Sentinel analysis of rickettsial diseases in international travelers

African tick bite fever in travelers to rural sub-equatorial Africa

DHR-ICMR guidelines for diagnosis & management of rickettsial diseases in India

Laboratory diagnosis of Mediterranean spotted fever by immunofluorescent demonstration of rickettsia conorii in cutaneous lesions

Underdiagnoses of rickettsia in patients hospitalized with acute fever in Indonesia: observational study results

Rickettsia spp. 364D causing a cluster of eschar-associated illness, California

Lower extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death

Disseminated intravascular coagulation: a devastating systemic disorder of special concern with COVID -19

The rash that leads to eschar formation

Coronavirus Disease (COVID-19) Treatment Guidelines. National Institutes of Health

Controlled randomized clinical trial on using ivermectin with doxycycline for treating COVID-19 patients in Baghdad. Iraq medRxiv

Iloprost for COVID-19-related vasculopathy

Severe COVID-19 is a microvascular disease

Diagnostic methods used to classify confirmed and probable cases of spotted fever rickettsioses -United States

Recognition and treatment of devastating vasculopathic systemic disorders: Coronavirus disease 2019 and rickettsioses